1 Min Read
Sept 19 (Reuters) - Boston Scientific Corp
* Boston Scientific announces positive late-breaking clinical trial data for the Heartlogic Heart Failure Diagnostic Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.